BNTC Benitec Biopharma Inc.
Nasdaq · SEC CIK 1808898 · EDGAR
- Bought, last 12 months
- $22.44M 3 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 45 since 2021-12-09, latest 2026-06-30 16:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | $20.00M | — |
| Cowen Aaron | Dir, 10% | $1.90M | — |
| Averill Madison Master Fund, Ltd. | 10% | $539.0K | — |
| BUCHI J KEVIN | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 16:20 | 2026-06-29 | BNTC | BUCHI J KEVIN | Dir | G - Gift | $0.00 | -51.8K | 52.1K | -50% | $0 | |
| MI | 2025-12-29 | 2025-12-23+ | BNTC | Cowen Aaron | Dir, 10% | P - Purchase | $13.20 | +144.2K | 1.85M | +8% | +$1.90M |
| MI | 2025-12-22 | 2025-12-18+ | BNTC | Averill Madison Master Fund, Ltd. | 10% | P - Purchase | $11.68 | +46.1K | 1.83M | +3% | +$539.0K |
| MI | 2025-11-10 | 2025-11-07 | BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | P - Purchase | $13.50 | +1.48M | 9.54M | +18% | +$20.00M |
| MI | 2025-04-02 | 2025-03-31 | BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | P - Purchase | $12.83 | +16.5K | 1.07M | +2% | +$211.7K |
| MI | 2025-03-28 | 2025-03-26 | BNTC | Cowen Aaron | 10% | P - Purchase | $13.00 | +900.0K | 1.07M | +540% | +$11.70M |
| 2025-03-13 | 2025-03-12 | BNTC | BUCHI J KEVIN | Dir | G - Gift | $0.00 | -103.6K | 284 | -100% | $0 | |
| I | 2025-03-13 | 2025-03-12 | BNTC | BUCHI J KEVIN | Dir | G - Gift | $0.00 | +103.6K | 103.6K | New | $0 |
| D | 2025-03-03 | 2025-02-27 | BNTC | BUCHI J KEVIN | Dir | M - OptEx | $3.86 | +51.8K | 103.9K | +99% | +$200.0K |
| MI | 2024-12-26 | 2024-12-23+ | BNTC | Cowen Aaron | 10% | P - Purchase | $11.09 | +47.5K | 958.3K | +5% | +$527.2K |
| MI | 2024-12-05 | 2024-12-03 | BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | P - Purchase | $9.60 | +42.0K | 7.96M | +0.5% | +$403.2K |
| MI | 2024-11-21 | 2024-11-19+ | BNTC | Averill Master Fund, Ltd. | Dir, 10% | P - Purchase | $10.05 | +41.4K | 7.90M | +0.5% | +$416.6K |
| DMI | 2024-09-30 | 2024-09-26 | BNTC | Averill Master Fund, Ltd. | Dir, 10% | X - OptEx | $2.96 | +7.14M | 6.66M | New | +$21.14M |
| D | 2023-08-14 | 2023-08-11 | BNTC | Boston Megan | Executive Dir, Dir | P - Purchase | — | +25.9K | 25.9K | New | — |
| D | 2023-08-14 | 2023-08-11 | BNTC | BUCHI J KEVIN | Dir | P - Purchase | — | +51.8K | 52.1K | +18,244% | — |
| MI | 2021-12-09 | 2021-04-28+ | BNTC | Oliveira Steven Michael | 10% | P - Purchase | $4.51 | +331.9K | 911.0K | +57% | +$1.50M |
Purchase Sale Sale after option exercise All abbreviations